Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Harmony Biosciences Holdings (HRMY) Debt Ratio (2019 - 2025)

Harmony Biosciences Holdings' Debt Ratio history spans 7 years, with the latest figure at 0.13 for Q4 2025.

  • For Q4 2025, Debt Ratio fell 28.26% year-over-year to 0.13; the TTM value through Dec 2025 reached 0.13, down 28.26%, while the annual FY2025 figure was 0.13, 28.26% down from the prior year.
  • Debt Ratio for Q4 2025 was 0.13 at Harmony Biosciences Holdings, down from 0.14 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.58 in Q1 2021 and bottomed at 0.13 in Q4 2025.
  • The 5-year median for Debt Ratio is 0.25 (2023), against an average of 0.29.
  • The largest annual shift saw Debt Ratio decreased 2.62% in 2021 before it tumbled 39.33% in 2022.
  • A 5-year view of Debt Ratio shows it stood at 0.44 in 2021, then tumbled by 35.79% to 0.28 in 2022, then fell by 16.12% to 0.24 in 2023, then dropped by 24.79% to 0.18 in 2024, then decreased by 28.26% to 0.13 in 2025.
  • Per Business Quant, the three most recent readings for HRMY's Debt Ratio are 0.13 (Q4 2025), 0.14 (Q3 2025), and 0.16 (Q2 2025).